Salt CompositionEnclomiphene 50mg
You Searched
EN-Clofert 50 Tablet
Maneesh Pharmaceuticals Ltd.
₹204.5
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Female infertility
Customers also bought
More About EN-Clofert
Benefits
In Female infertility EN-Clofert 50 Tablet helps in normal development of an egg in a woman's ovary (female reproductive organ), and stimulates the release of a healthy, matured egg. This helps to treat infertility in women and increases the chance of a successful pregnancy. It is commonly used in women who are taking treatment for ovulation related issues or for polycystic ovary syndrome (PCOS). Take this medicine in the dose and duration prescribed by the doctor.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. EN-Clofert 50 Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
EN-Clofert 50 Tablet is a selective estrogen receptor modulator (SERM) which treats female infertility. It works by promoting the release of reproductive hormones. This helps stimulate the release of eggs from the ovary (ovulation).
Caution: It is important to consult your doctor regarding alcohol consumption while taking EN-Clofert 50 Tablet .
Not Safe: EN-Clofert 50 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Seek medical advice from your doctor: EN-Clofert 50 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: EN-Clofert 50 Tablet may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Seek medical advice from your doctor: There is limited information available on the use of EN-Clofert 50 Tablet in patients with kidney disease. Doctor consultation is advised.
Not Safe: EN-Clofert 50 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Doctor consultation is advised.
What if I forget to take it?
If a dose of EN-Clofert 50 Tablet is missed, it's advisable to consult your doctor.
Manufacturer Address
Plot No. 29-33, Ancillary Industrial Plots, Govandi, Mumbai - 400 043.
References
Clomiphene. Bridgewater, New Jersey: Sanofi-Aventis U.S.; 2012 (03 Apr. 2019)
Mestra Pharma. Enclomiphene Citrate (28 Aug. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
